Global Antihistamine Drugs Market

Antihistamine Drugs Comprehensive Study by Type (Sedating (Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others), Non-Sedating Antihistamines (Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others)), Application (Allergy, Urticaria, Dermatitis, Conjunctivitis, Others), Route of Administration (Oral Route, Parenteral Route (Intramuscular, Subcutaneous and Intravenous Route.), Rectal Route), Form (Tablets & Capsules, Topical, Nasal Sprays, Eye Drops, Others), Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies) Players and Region - Global Market Outlook to 2030

Antihistamine Drugs Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Antihistamine Drugs Market Scope
Antihistamines are used to treat allergic conditions that result from the release of histamine. Antihistamines market has high growth prospects owing to the increasing geriatric population and rising prevalence of skin allergies. Further, growing healthcare infratstrure in the developing economies and research and development in the healthcare industry expected to drive the demand for antihistamines drugs over the forecasted period.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledJohnson & Johnson Consumer Inc. (United States), Sanofi (France), Bayer AG (Germany), Pfizer (United States), CVS pharmacy (United States), Merck & Co., Inc. (United States), Prestige Brands Holdings, Inc. (United States), Novartis (Switzerland), Teva Pharmaceutical (Israel), Boehringer Ingelheim (Germany), AstraZeneca (United Kingdom) and Mylan (United States)
CAGR%


Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Research Analyst at AMA estimates that United States & European Players will contribute to the maximum growth of Global Antihistamine Drugs market throughout the predicted period.

Johnson & Johnson Consumer Inc. (United States), Sanofi (France), Bayer AG (Germany), Pfizer (United States), CVS pharmacy (United States), Merck & Co., Inc. (United States), Prestige Brands Holdings, Inc. (United States), Novartis (Switzerland), Teva Pharmaceutical (Israel), Boehringer Ingelheim (Germany), AstraZeneca (United Kingdom) and Mylan (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Antihistamine Drugs market by Type , by Application (Allergy, Urticaria, Dermatitis, Conjunctivitis and Others) and Region with country level break-up.

On the basis of geography, the market of Antihistamine Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.




Influencing Trend:
Research and Development in the Healthcare Industry

Market Growth Drivers:
Growing Prevalence of Skin Allergies and Rising Geriatric Population

Challenges:
Lack of Awareness in the Emerging Economies and Intense Competition among Market Players

Restraints:
Stringent Government Regulations Regarding Medical Drugs and Side Effects May Cause Such As Dry Mouth, Dizziness, Nervousness, Decreased Appetite, and Blurred Vision

Opportunities:
Technological Advancement in the Healthcare Industry and Growing Healthcare Infrastructure in the Developing Economies

Key Target Audience
Antihistamine Drug Manufacturers, Antihistamine Drug Suppliers, Medical Research Laboratories, Research and Development (R&D) Companies, Market Research and Consulting Service Providers, Potential Investors and Others

Report Objectives / Segmentation Covered

By Type
  • Sedating [Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others]
  • Non-Sedating Antihistamines [Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others]
By Application
  • Allergy
  • Urticaria
  • Dermatitis
  • Conjunctivitis
  • Others
By Route of Administration
  • Oral Route
  • Parenteral Route [Intramuscular, Subcutaneous and Intravenous Route.]
  • Rectal Route

By Form
  • Tablets & Capsules
  • Topical
  • Nasal Sprays
  • Eye Drops
  • Others

By Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Skin Allergies
      • 3.2.2. Rising Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness in the Emerging Economies
      • 3.3.2. Intense Competition among Market Players
    • 3.4. Market Trends
      • 3.4.1. Research and Development in the Healthcare Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antihistamine Drugs, by Type, Application, Route of Administration, Form, Distribution Channel and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Antihistamine Drugs (Value)
      • 5.2.1. Global Antihistamine Drugs by: Type (Value)
        • 5.2.1.1. Sedating [Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others]
        • 5.2.1.2. Non-Sedating Antihistamines [Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others]
      • 5.2.2. Global Antihistamine Drugs by: Application (Value)
        • 5.2.2.1. Allergy
        • 5.2.2.2. Urticaria
        • 5.2.2.3. Dermatitis
        • 5.2.2.4. Conjunctivitis
        • 5.2.2.5. Others
      • 5.2.3. Global Antihistamine Drugs by: Route of Administration (Value)
        • 5.2.3.1. Oral Route
        • 5.2.3.2. Parenteral Route [Intramuscular, Subcutaneous and Intravenous Route.]
        • 5.2.3.3. Rectal Route
      • 5.2.4. Global Antihistamine Drugs by: Form (Value)
        • 5.2.4.1. Tablets & Capsules
        • 5.2.4.2. Topical
        • 5.2.4.3. Nasal Sprays
        • 5.2.4.4. Eye Drops
        • 5.2.4.5. Others
      • 5.2.5. Global Antihistamine Drugs by: Distribution Channel (Value)
        • 5.2.5.1. Online Pharmacies
        • 5.2.5.2. Hospital Pharmacies
        • 5.2.5.3. Retail Pharmacies
      • 5.2.6. Global Antihistamine Drugs Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Antihistamine Drugs (Volume)
      • 5.3.1. Global Antihistamine Drugs by: Type (Volume)
        • 5.3.1.1. Sedating [Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others]
        • 5.3.1.2. Non-Sedating Antihistamines [Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others]
      • 5.3.2. Global Antihistamine Drugs by: Application (Volume)
        • 5.3.2.1. Allergy
        • 5.3.2.2. Urticaria
        • 5.3.2.3. Dermatitis
        • 5.3.2.4. Conjunctivitis
        • 5.3.2.5. Others
      • 5.3.3. Global Antihistamine Drugs by: Route of Administration (Volume)
        • 5.3.3.1. Oral Route
        • 5.3.3.2. Parenteral Route [Intramuscular, Subcutaneous and Intravenous Route.]
        • 5.3.3.3. Rectal Route
      • 5.3.4. Global Antihistamine Drugs by: Form (Volume)
        • 5.3.4.1. Tablets & Capsules
        • 5.3.4.2. Topical
        • 5.3.4.3. Nasal Sprays
        • 5.3.4.4. Eye Drops
        • 5.3.4.5. Others
      • 5.3.5. Global Antihistamine Drugs by: Distribution Channel (Volume)
        • 5.3.5.1. Online Pharmacies
        • 5.3.5.2. Hospital Pharmacies
        • 5.3.5.3. Retail Pharmacies
      • 5.3.6. Global Antihistamine Drugs Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Antihistamine Drugs (Price)
      • 5.4.1. Global Antihistamine Drugs by: Type (Price)
  • 6. Antihistamine Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson Consumer Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sanofi (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. CVS pharmacy (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck & Co., Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Prestige Brands Holdings, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Novartis (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Teva Pharmaceutical (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Boehringer Ingelheim (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. AstraZeneca (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Mylan (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Antihistamine Drugs Sale, by Type, Application, Route of Administration, Form, Distribution Channel and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Antihistamine Drugs (Value)
      • 7.2.1. Global Antihistamine Drugs by: Type (Value)
        • 7.2.1.1. Sedating [Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others]
        • 7.2.1.2. Non-Sedating Antihistamines [Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others]
      • 7.2.2. Global Antihistamine Drugs by: Application (Value)
        • 7.2.2.1. Allergy
        • 7.2.2.2. Urticaria
        • 7.2.2.3. Dermatitis
        • 7.2.2.4. Conjunctivitis
        • 7.2.2.5. Others
      • 7.2.3. Global Antihistamine Drugs by: Route of Administration (Value)
        • 7.2.3.1. Oral Route
        • 7.2.3.2. Parenteral Route [Intramuscular, Subcutaneous and Intravenous Route.]
        • 7.2.3.3. Rectal Route
      • 7.2.4. Global Antihistamine Drugs by: Form (Value)
        • 7.2.4.1. Tablets & Capsules
        • 7.2.4.2. Topical
        • 7.2.4.3. Nasal Sprays
        • 7.2.4.4. Eye Drops
        • 7.2.4.5. Others
      • 7.2.5. Global Antihistamine Drugs by: Distribution Channel (Value)
        • 7.2.5.1. Online Pharmacies
        • 7.2.5.2. Hospital Pharmacies
        • 7.2.5.3. Retail Pharmacies
      • 7.2.6. Global Antihistamine Drugs Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Antihistamine Drugs (Volume)
      • 7.3.1. Global Antihistamine Drugs by: Type (Volume)
        • 7.3.1.1. Sedating [Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others]
        • 7.3.1.2. Non-Sedating Antihistamines [Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others]
      • 7.3.2. Global Antihistamine Drugs by: Application (Volume)
        • 7.3.2.1. Allergy
        • 7.3.2.2. Urticaria
        • 7.3.2.3. Dermatitis
        • 7.3.2.4. Conjunctivitis
        • 7.3.2.5. Others
      • 7.3.3. Global Antihistamine Drugs by: Route of Administration (Volume)
        • 7.3.3.1. Oral Route
        • 7.3.3.2. Parenteral Route [Intramuscular, Subcutaneous and Intravenous Route.]
        • 7.3.3.3. Rectal Route
      • 7.3.4. Global Antihistamine Drugs by: Form (Volume)
        • 7.3.4.1. Tablets & Capsules
        • 7.3.4.2. Topical
        • 7.3.4.3. Nasal Sprays
        • 7.3.4.4. Eye Drops
        • 7.3.4.5. Others
      • 7.3.5. Global Antihistamine Drugs by: Distribution Channel (Volume)
        • 7.3.5.1. Online Pharmacies
        • 7.3.5.2. Hospital Pharmacies
        • 7.3.5.3. Retail Pharmacies
      • 7.3.6. Global Antihistamine Drugs Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Antihistamine Drugs (Price)
      • 7.4.1. Global Antihistamine Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antihistamine Drugs: by Type(USD Million)
  • Table 2. Antihistamine Drugs Sedating [Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others] , by Region USD Million (2018-2023)
  • Table 3. Antihistamine Drugs Non-Sedating Antihistamines [Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others] , by Region USD Million (2018-2023)
  • Table 4. Antihistamine Drugs: by Application(USD Million)
  • Table 5. Antihistamine Drugs Allergy , by Region USD Million (2018-2023)
  • Table 6. Antihistamine Drugs Urticaria , by Region USD Million (2018-2023)
  • Table 7. Antihistamine Drugs Dermatitis , by Region USD Million (2018-2023)
  • Table 8. Antihistamine Drugs Conjunctivitis , by Region USD Million (2018-2023)
  • Table 9. Antihistamine Drugs Others , by Region USD Million (2018-2023)
  • Table 10. Antihistamine Drugs: by Route of Administration(USD Million)
  • Table 11. Antihistamine Drugs Oral Route , by Region USD Million (2018-2023)
  • Table 12. Antihistamine Drugs Parenteral Route [Intramuscular, Subcutaneous and Intravenous Route.] , by Region USD Million (2018-2023)
  • Table 13. Antihistamine Drugs Rectal Route , by Region USD Million (2018-2023)
  • Table 14. Antihistamine Drugs: by Form(USD Million)
  • Table 15. Antihistamine Drugs Tablets & Capsules , by Region USD Million (2018-2023)
  • Table 16. Antihistamine Drugs Topical , by Region USD Million (2018-2023)
  • Table 17. Antihistamine Drugs Nasal Sprays , by Region USD Million (2018-2023)
  • Table 18. Antihistamine Drugs Eye Drops , by Region USD Million (2018-2023)
  • Table 19. Antihistamine Drugs Others , by Region USD Million (2018-2023)
  • Table 20. Antihistamine Drugs: by Distribution Channel(USD Million)
  • Table 21. Antihistamine Drugs Online Pharmacies , by Region USD Million (2018-2023)
  • Table 22. Antihistamine Drugs Hospital Pharmacies , by Region USD Million (2018-2023)
  • Table 23. Antihistamine Drugs Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 24. South America Antihistamine Drugs, by Country USD Million (2018-2023)
  • Table 25. South America Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 26. South America Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 27. South America Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 28. South America Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 29. South America Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 30. Brazil Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 31. Brazil Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 32. Brazil Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 33. Brazil Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 34. Brazil Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 35. Argentina Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 36. Argentina Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 37. Argentina Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 38. Argentina Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 39. Argentina Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 40. Rest of South America Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 41. Rest of South America Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 42. Rest of South America Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 43. Rest of South America Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 44. Rest of South America Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 45. Asia Pacific Antihistamine Drugs, by Country USD Million (2018-2023)
  • Table 46. Asia Pacific Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 47. Asia Pacific Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 48. Asia Pacific Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 49. Asia Pacific Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 50. Asia Pacific Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 51. China Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 52. China Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 53. China Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 54. China Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 55. China Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 56. Japan Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 57. Japan Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 58. Japan Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 59. Japan Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 60. Japan Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 61. India Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 62. India Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 63. India Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 64. India Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 65. India Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 66. South Korea Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 67. South Korea Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 68. South Korea Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 69. South Korea Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 70. South Korea Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 71. Taiwan Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 72. Taiwan Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 73. Taiwan Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 74. Taiwan Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 75. Taiwan Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 76. Australia Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 77. Australia Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 78. Australia Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 79. Australia Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 80. Australia Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 81. Rest of Asia-Pacific Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 82. Rest of Asia-Pacific Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 84. Rest of Asia-Pacific Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 85. Rest of Asia-Pacific Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 86. Europe Antihistamine Drugs, by Country USD Million (2018-2023)
  • Table 87. Europe Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 88. Europe Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 89. Europe Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 90. Europe Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 91. Europe Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 92. Germany Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 93. Germany Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 94. Germany Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 95. Germany Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 96. Germany Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 97. France Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 98. France Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 99. France Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 100. France Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 101. France Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 102. Italy Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 103. Italy Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 104. Italy Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 105. Italy Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 106. Italy Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 107. United Kingdom Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 108. United Kingdom Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 109. United Kingdom Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 110. United Kingdom Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 111. United Kingdom Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 112. Netherlands Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 113. Netherlands Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 114. Netherlands Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 115. Netherlands Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 116. Netherlands Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 117. Rest of Europe Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 118. Rest of Europe Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 119. Rest of Europe Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 120. Rest of Europe Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 121. Rest of Europe Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 122. MEA Antihistamine Drugs, by Country USD Million (2018-2023)
  • Table 123. MEA Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 124. MEA Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 125. MEA Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 126. MEA Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 127. MEA Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 128. Middle East Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 129. Middle East Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 130. Middle East Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 131. Middle East Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 132. Middle East Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 133. Africa Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 134. Africa Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 135. Africa Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 136. Africa Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 137. Africa Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 138. North America Antihistamine Drugs, by Country USD Million (2018-2023)
  • Table 139. North America Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 140. North America Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 141. North America Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 142. North America Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 143. North America Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 144. United States Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 145. United States Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 146. United States Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 147. United States Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 148. United States Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 149. Canada Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 150. Canada Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 151. Canada Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 152. Canada Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 153. Canada Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 154. Mexico Antihistamine Drugs, by Type USD Million (2018-2023)
  • Table 155. Mexico Antihistamine Drugs, by Application USD Million (2018-2023)
  • Table 156. Mexico Antihistamine Drugs, by Route of Administration USD Million (2018-2023)
  • Table 157. Mexico Antihistamine Drugs, by Form USD Million (2018-2023)
  • Table 158. Mexico Antihistamine Drugs, by Distribution Channel USD Million (2018-2023)
  • Table 159. Antihistamine Drugs Sales: by Type(K Tons)
  • Table 160. Antihistamine Drugs Sales Sedating [Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others] , by Region K Tons (2018-2023)
  • Table 161. Antihistamine Drugs Sales Non-Sedating Antihistamines [Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others] , by Region K Tons (2018-2023)
  • Table 162. Antihistamine Drugs Sales: by Application(K Tons)
  • Table 163. Antihistamine Drugs Sales Allergy , by Region K Tons (2018-2023)
  • Table 164. Antihistamine Drugs Sales Urticaria , by Region K Tons (2018-2023)
  • Table 165. Antihistamine Drugs Sales Dermatitis , by Region K Tons (2018-2023)
  • Table 166. Antihistamine Drugs Sales Conjunctivitis , by Region K Tons (2018-2023)
  • Table 167. Antihistamine Drugs Sales Others , by Region K Tons (2018-2023)
  • Table 168. Antihistamine Drugs Sales: by Route of Administration(K Tons)
  • Table 169. Antihistamine Drugs Sales Oral Route , by Region K Tons (2018-2023)
  • Table 170. Antihistamine Drugs Sales Parenteral Route [Intramuscular, Subcutaneous and Intravenous Route.] , by Region K Tons (2018-2023)
  • Table 171. Antihistamine Drugs Sales Rectal Route , by Region K Tons (2018-2023)
  • Table 172. Antihistamine Drugs Sales: by Form(K Tons)
  • Table 173. Antihistamine Drugs Sales Tablets & Capsules , by Region K Tons (2018-2023)
  • Table 174. Antihistamine Drugs Sales Topical , by Region K Tons (2018-2023)
  • Table 175. Antihistamine Drugs Sales Nasal Sprays , by Region K Tons (2018-2023)
  • Table 176. Antihistamine Drugs Sales Eye Drops , by Region K Tons (2018-2023)
  • Table 177. Antihistamine Drugs Sales Others , by Region K Tons (2018-2023)
  • Table 178. Antihistamine Drugs Sales: by Distribution Channel(K Tons)
  • Table 179. Antihistamine Drugs Sales Online Pharmacies , by Region K Tons (2018-2023)
  • Table 180. Antihistamine Drugs Sales Hospital Pharmacies , by Region K Tons (2018-2023)
  • Table 181. Antihistamine Drugs Sales Retail Pharmacies , by Region K Tons (2018-2023)
  • Table 182. South America Antihistamine Drugs Sales, by Country K Tons (2018-2023)
  • Table 183. South America Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 184. South America Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 185. South America Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 186. South America Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 187. South America Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 188. Brazil Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 189. Brazil Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 190. Brazil Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 191. Brazil Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 192. Brazil Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 193. Argentina Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 194. Argentina Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 195. Argentina Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 196. Argentina Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 197. Argentina Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 198. Rest of South America Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 199. Rest of South America Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 200. Rest of South America Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 201. Rest of South America Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 202. Rest of South America Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 203. Asia Pacific Antihistamine Drugs Sales, by Country K Tons (2018-2023)
  • Table 204. Asia Pacific Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 205. Asia Pacific Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 206. Asia Pacific Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 207. Asia Pacific Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 208. Asia Pacific Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 209. China Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 210. China Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 211. China Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 212. China Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 213. China Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 214. Japan Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 215. Japan Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 216. Japan Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 217. Japan Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 218. Japan Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 219. India Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 220. India Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 221. India Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 222. India Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 223. India Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 224. South Korea Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 225. South Korea Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 226. South Korea Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 227. South Korea Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 228. South Korea Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 229. Taiwan Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 230. Taiwan Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 231. Taiwan Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 232. Taiwan Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 233. Taiwan Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 234. Australia Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 235. Australia Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 236. Australia Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 237. Australia Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 238. Australia Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 239. Rest of Asia-Pacific Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 240. Rest of Asia-Pacific Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 241. Rest of Asia-Pacific Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 242. Rest of Asia-Pacific Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 243. Rest of Asia-Pacific Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 244. Europe Antihistamine Drugs Sales, by Country K Tons (2018-2023)
  • Table 245. Europe Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 246. Europe Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 247. Europe Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 248. Europe Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 249. Europe Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 250. Germany Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 251. Germany Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 252. Germany Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 253. Germany Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 254. Germany Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 255. France Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 256. France Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 257. France Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 258. France Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 259. France Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 260. Italy Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 261. Italy Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 262. Italy Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 263. Italy Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 264. Italy Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 265. United Kingdom Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 266. United Kingdom Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 267. United Kingdom Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 268. United Kingdom Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 269. United Kingdom Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 270. Netherlands Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 271. Netherlands Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 272. Netherlands Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 273. Netherlands Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 274. Netherlands Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 275. Rest of Europe Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 276. Rest of Europe Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 277. Rest of Europe Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 278. Rest of Europe Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 279. Rest of Europe Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 280. MEA Antihistamine Drugs Sales, by Country K Tons (2018-2023)
  • Table 281. MEA Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 282. MEA Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 283. MEA Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 284. MEA Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 285. MEA Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 286. Middle East Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 287. Middle East Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 288. Middle East Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 289. Middle East Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 290. Middle East Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 291. Africa Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 292. Africa Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 293. Africa Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 294. Africa Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 295. Africa Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 296. North America Antihistamine Drugs Sales, by Country K Tons (2018-2023)
  • Table 297. North America Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 298. North America Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 299. North America Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 300. North America Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 301. North America Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 302. United States Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 303. United States Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 304. United States Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 305. United States Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 306. United States Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 307. Canada Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 308. Canada Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 309. Canada Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 310. Canada Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 311. Canada Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 312. Mexico Antihistamine Drugs Sales, by Type K Tons (2018-2023)
  • Table 313. Mexico Antihistamine Drugs Sales, by Application K Tons (2018-2023)
  • Table 314. Mexico Antihistamine Drugs Sales, by Route of Administration K Tons (2018-2023)
  • Table 315. Mexico Antihistamine Drugs Sales, by Form K Tons (2018-2023)
  • Table 316. Mexico Antihistamine Drugs Sales, by Distribution Channel K Tons (2018-2023)
  • Table 317. Antihistamine Drugs: by Type(USD/Units)
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Company Basic Information, Sales Area and Its Competitors
  • Table 329. Company Basic Information, Sales Area and Its Competitors
  • Table 330. Antihistamine Drugs: by Type(USD Million)
  • Table 331. Antihistamine Drugs Sedating [Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others] , by Region USD Million (2025-2030)
  • Table 332. Antihistamine Drugs Non-Sedating Antihistamines [Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others] , by Region USD Million (2025-2030)
  • Table 333. Antihistamine Drugs: by Application(USD Million)
  • Table 334. Antihistamine Drugs Allergy , by Region USD Million (2025-2030)
  • Table 335. Antihistamine Drugs Urticaria , by Region USD Million (2025-2030)
  • Table 336. Antihistamine Drugs Dermatitis , by Region USD Million (2025-2030)
  • Table 337. Antihistamine Drugs Conjunctivitis , by Region USD Million (2025-2030)
  • Table 338. Antihistamine Drugs Others , by Region USD Million (2025-2030)
  • Table 339. Antihistamine Drugs: by Route of Administration(USD Million)
  • Table 340. Antihistamine Drugs Oral Route , by Region USD Million (2025-2030)
  • Table 341. Antihistamine Drugs Parenteral Route [Intramuscular, Subcutaneous and Intravenous Route.] , by Region USD Million (2025-2030)
  • Table 342. Antihistamine Drugs Rectal Route , by Region USD Million (2025-2030)
  • Table 343. Antihistamine Drugs: by Form(USD Million)
  • Table 344. Antihistamine Drugs Tablets & Capsules , by Region USD Million (2025-2030)
  • Table 345. Antihistamine Drugs Topical , by Region USD Million (2025-2030)
  • Table 346. Antihistamine Drugs Nasal Sprays , by Region USD Million (2025-2030)
  • Table 347. Antihistamine Drugs Eye Drops , by Region USD Million (2025-2030)
  • Table 348. Antihistamine Drugs Others , by Region USD Million (2025-2030)
  • Table 349. Antihistamine Drugs: by Distribution Channel(USD Million)
  • Table 350. Antihistamine Drugs Online Pharmacies , by Region USD Million (2025-2030)
  • Table 351. Antihistamine Drugs Hospital Pharmacies , by Region USD Million (2025-2030)
  • Table 352. Antihistamine Drugs Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 353. South America Antihistamine Drugs, by Country USD Million (2025-2030)
  • Table 354. South America Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 355. South America Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 356. South America Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 357. South America Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 358. South America Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 359. Brazil Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 360. Brazil Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 361. Brazil Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 362. Brazil Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 363. Brazil Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 364. Argentina Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 365. Argentina Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 366. Argentina Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 367. Argentina Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 368. Argentina Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 369. Rest of South America Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 370. Rest of South America Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 371. Rest of South America Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 372. Rest of South America Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 373. Rest of South America Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 374. Asia Pacific Antihistamine Drugs, by Country USD Million (2025-2030)
  • Table 375. Asia Pacific Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 376. Asia Pacific Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 377. Asia Pacific Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 378. Asia Pacific Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 379. Asia Pacific Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 380. China Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 381. China Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 382. China Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 383. China Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 384. China Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 385. Japan Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 386. Japan Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 387. Japan Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 388. Japan Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 389. Japan Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 390. India Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 391. India Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 392. India Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 393. India Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 394. India Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 395. South Korea Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 396. South Korea Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 397. South Korea Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 398. South Korea Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 399. South Korea Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 400. Taiwan Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 401. Taiwan Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 402. Taiwan Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 403. Taiwan Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 404. Taiwan Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 405. Australia Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 406. Australia Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 407. Australia Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 408. Australia Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 409. Australia Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 410. Rest of Asia-Pacific Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 411. Rest of Asia-Pacific Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 412. Rest of Asia-Pacific Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 413. Rest of Asia-Pacific Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 414. Rest of Asia-Pacific Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 415. Europe Antihistamine Drugs, by Country USD Million (2025-2030)
  • Table 416. Europe Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 417. Europe Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 418. Europe Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 419. Europe Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 420. Europe Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 421. Germany Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 422. Germany Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 423. Germany Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 424. Germany Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 425. Germany Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 426. France Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 427. France Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 428. France Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 429. France Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 430. France Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 431. Italy Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 432. Italy Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 433. Italy Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 434. Italy Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 435. Italy Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 436. United Kingdom Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 437. United Kingdom Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 438. United Kingdom Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 439. United Kingdom Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 440. United Kingdom Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 441. Netherlands Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 442. Netherlands Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 443. Netherlands Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 444. Netherlands Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 445. Netherlands Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 446. Rest of Europe Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 447. Rest of Europe Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 448. Rest of Europe Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 449. Rest of Europe Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 450. Rest of Europe Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 451. MEA Antihistamine Drugs, by Country USD Million (2025-2030)
  • Table 452. MEA Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 453. MEA Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 454. MEA Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 455. MEA Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 456. MEA Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 457. Middle East Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 458. Middle East Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 459. Middle East Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 460. Middle East Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 461. Middle East Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 462. Africa Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 463. Africa Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 464. Africa Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 465. Africa Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 466. Africa Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 467. North America Antihistamine Drugs, by Country USD Million (2025-2030)
  • Table 468. North America Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 469. North America Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 470. North America Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 471. North America Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 472. North America Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 473. United States Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 474. United States Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 475. United States Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 476. United States Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 477. United States Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 478. Canada Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 479. Canada Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 480. Canada Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 481. Canada Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 482. Canada Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 483. Mexico Antihistamine Drugs, by Type USD Million (2025-2030)
  • Table 484. Mexico Antihistamine Drugs, by Application USD Million (2025-2030)
  • Table 485. Mexico Antihistamine Drugs, by Route of Administration USD Million (2025-2030)
  • Table 486. Mexico Antihistamine Drugs, by Form USD Million (2025-2030)
  • Table 487. Mexico Antihistamine Drugs, by Distribution Channel USD Million (2025-2030)
  • Table 488. Antihistamine Drugs Sales: by Type(K Tons)
  • Table 489. Antihistamine Drugs Sales Sedating [Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others] , by Region K Tons (2025-2030)
  • Table 490. Antihistamine Drugs Sales Non-Sedating Antihistamines [Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others] , by Region K Tons (2025-2030)
  • Table 491. Antihistamine Drugs Sales: by Application(K Tons)
  • Table 492. Antihistamine Drugs Sales Allergy , by Region K Tons (2025-2030)
  • Table 493. Antihistamine Drugs Sales Urticaria , by Region K Tons (2025-2030)
  • Table 494. Antihistamine Drugs Sales Dermatitis , by Region K Tons (2025-2030)
  • Table 495. Antihistamine Drugs Sales Conjunctivitis , by Region K Tons (2025-2030)
  • Table 496. Antihistamine Drugs Sales Others , by Region K Tons (2025-2030)
  • Table 497. Antihistamine Drugs Sales: by Route of Administration(K Tons)
  • Table 498. Antihistamine Drugs Sales Oral Route , by Region K Tons (2025-2030)
  • Table 499. Antihistamine Drugs Sales Parenteral Route [Intramuscular, Subcutaneous and Intravenous Route.] , by Region K Tons (2025-2030)
  • Table 500. Antihistamine Drugs Sales Rectal Route , by Region K Tons (2025-2030)
  • Table 501. Antihistamine Drugs Sales: by Form(K Tons)
  • Table 502. Antihistamine Drugs Sales Tablets & Capsules , by Region K Tons (2025-2030)
  • Table 503. Antihistamine Drugs Sales Topical , by Region K Tons (2025-2030)
  • Table 504. Antihistamine Drugs Sales Nasal Sprays , by Region K Tons (2025-2030)
  • Table 505. Antihistamine Drugs Sales Eye Drops , by Region K Tons (2025-2030)
  • Table 506. Antihistamine Drugs Sales Others , by Region K Tons (2025-2030)
  • Table 507. Antihistamine Drugs Sales: by Distribution Channel(K Tons)
  • Table 508. Antihistamine Drugs Sales Online Pharmacies , by Region K Tons (2025-2030)
  • Table 509. Antihistamine Drugs Sales Hospital Pharmacies , by Region K Tons (2025-2030)
  • Table 510. Antihistamine Drugs Sales Retail Pharmacies , by Region K Tons (2025-2030)
  • Table 511. South America Antihistamine Drugs Sales, by Country K Tons (2025-2030)
  • Table 512. South America Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 513. South America Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 514. South America Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 515. South America Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 516. South America Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 517. Brazil Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 518. Brazil Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 519. Brazil Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 520. Brazil Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 521. Brazil Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 522. Argentina Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 523. Argentina Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 524. Argentina Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 525. Argentina Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 526. Argentina Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 527. Rest of South America Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 528. Rest of South America Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 529. Rest of South America Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 530. Rest of South America Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 531. Rest of South America Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 532. Asia Pacific Antihistamine Drugs Sales, by Country K Tons (2025-2030)
  • Table 533. Asia Pacific Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 534. Asia Pacific Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 535. Asia Pacific Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 536. Asia Pacific Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 537. Asia Pacific Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 538. China Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 539. China Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 540. China Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 541. China Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 542. China Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 543. Japan Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 544. Japan Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 545. Japan Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 546. Japan Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 547. Japan Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 548. India Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 549. India Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 550. India Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 551. India Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 552. India Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 553. South Korea Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 554. South Korea Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 555. South Korea Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 556. South Korea Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 557. South Korea Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 558. Taiwan Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 559. Taiwan Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 560. Taiwan Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 561. Taiwan Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 562. Taiwan Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 563. Australia Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 564. Australia Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 565. Australia Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 566. Australia Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 567. Australia Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 568. Rest of Asia-Pacific Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 569. Rest of Asia-Pacific Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 570. Rest of Asia-Pacific Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 571. Rest of Asia-Pacific Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 572. Rest of Asia-Pacific Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 573. Europe Antihistamine Drugs Sales, by Country K Tons (2025-2030)
  • Table 574. Europe Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 575. Europe Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 576. Europe Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 577. Europe Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 578. Europe Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 579. Germany Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 580. Germany Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 581. Germany Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 582. Germany Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 583. Germany Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 584. France Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 585. France Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 586. France Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 587. France Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 588. France Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 589. Italy Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 590. Italy Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 591. Italy Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 592. Italy Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 593. Italy Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 594. United Kingdom Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 595. United Kingdom Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 596. United Kingdom Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 597. United Kingdom Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 598. United Kingdom Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 599. Netherlands Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 600. Netherlands Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 601. Netherlands Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 602. Netherlands Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 603. Netherlands Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 604. Rest of Europe Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 605. Rest of Europe Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 606. Rest of Europe Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 607. Rest of Europe Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 608. Rest of Europe Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 609. MEA Antihistamine Drugs Sales, by Country K Tons (2025-2030)
  • Table 610. MEA Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 611. MEA Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 612. MEA Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 613. MEA Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 614. MEA Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 615. Middle East Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 616. Middle East Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 617. Middle East Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 618. Middle East Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 619. Middle East Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 620. Africa Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 621. Africa Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 622. Africa Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 623. Africa Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 624. Africa Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 625. North America Antihistamine Drugs Sales, by Country K Tons (2025-2030)
  • Table 626. North America Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 627. North America Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 628. North America Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 629. North America Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 630. North America Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 631. United States Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 632. United States Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 633. United States Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 634. United States Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 635. United States Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 636. Canada Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 637. Canada Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 638. Canada Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 639. Canada Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 640. Canada Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 641. Mexico Antihistamine Drugs Sales, by Type K Tons (2025-2030)
  • Table 642. Mexico Antihistamine Drugs Sales, by Application K Tons (2025-2030)
  • Table 643. Mexico Antihistamine Drugs Sales, by Route of Administration K Tons (2025-2030)
  • Table 644. Mexico Antihistamine Drugs Sales, by Form K Tons (2025-2030)
  • Table 645. Mexico Antihistamine Drugs Sales, by Distribution Channel K Tons (2025-2030)
  • Table 646. Antihistamine Drugs: by Type(USD/Units)
  • Table 647. Research Programs/Design for This Report
  • Table 648. Key Data Information from Secondary Sources
  • Table 649. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antihistamine Drugs: by Type USD Million (2018-2023)
  • Figure 5. Global Antihistamine Drugs: by Application USD Million (2018-2023)
  • Figure 6. Global Antihistamine Drugs: by Route of Administration USD Million (2018-2023)
  • Figure 7. Global Antihistamine Drugs: by Form USD Million (2018-2023)
  • Figure 8. Global Antihistamine Drugs: by Distribution Channel USD Million (2018-2023)
  • Figure 9. South America Antihistamine Drugs Share (%), by Country
  • Figure 10. Asia Pacific Antihistamine Drugs Share (%), by Country
  • Figure 11. Europe Antihistamine Drugs Share (%), by Country
  • Figure 12. MEA Antihistamine Drugs Share (%), by Country
  • Figure 13. North America Antihistamine Drugs Share (%), by Country
  • Figure 14. Global Antihistamine Drugs: by Type K Tons (2018-2023)
  • Figure 15. Global Antihistamine Drugs: by Application K Tons (2018-2023)
  • Figure 16. Global Antihistamine Drugs: by Route of Administration K Tons (2018-2023)
  • Figure 17. Global Antihistamine Drugs: by Form K Tons (2018-2023)
  • Figure 18. Global Antihistamine Drugs: by Distribution Channel K Tons (2018-2023)
  • Figure 19. South America Antihistamine Drugs Share (%), by Country
  • Figure 20. Asia Pacific Antihistamine Drugs Share (%), by Country
  • Figure 21. Europe Antihistamine Drugs Share (%), by Country
  • Figure 22. MEA Antihistamine Drugs Share (%), by Country
  • Figure 23. North America Antihistamine Drugs Share (%), by Country
  • Figure 24. Global Antihistamine Drugs: by Type USD/Units (2018-2023)
  • Figure 25. Global Antihistamine Drugs share by Players 2023 (%)
  • Figure 26. Global Antihistamine Drugs share by Players (Top 3) 2023(%)
  • Figure 27. Global Antihistamine Drugs share by Players (Top 5) 2023(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Johnson & Johnson Consumer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Johnson & Johnson Consumer Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 32. Sanofi (France) Revenue: by Geography 2023
  • Figure 33. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Bayer AG (Germany) Revenue: by Geography 2023
  • Figure 35. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 36. Pfizer (United States) Revenue: by Geography 2023
  • Figure 37. CVS pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 38. CVS pharmacy (United States) Revenue: by Geography 2023
  • Figure 39. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Merck & Co., Inc. (United States) Revenue: by Geography 2023
  • Figure 41. Prestige Brands Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Prestige Brands Holdings, Inc. (United States) Revenue: by Geography 2023
  • Figure 43. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 44. Novartis (Switzerland) Revenue: by Geography 2023
  • Figure 45. Teva Pharmaceutical (Israel) Revenue, Net Income and Gross profit
  • Figure 46. Teva Pharmaceutical (Israel) Revenue: by Geography 2023
  • Figure 47. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 48. Boehringer Ingelheim (Germany) Revenue: by Geography 2023
  • Figure 49. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 50. AstraZeneca (United Kingdom) Revenue: by Geography 2023
  • Figure 51. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 52. Mylan (United States) Revenue: by Geography 2023
  • Figure 53. Global Antihistamine Drugs: by Type USD Million (2025-2030)
  • Figure 54. Global Antihistamine Drugs: by Application USD Million (2025-2030)
  • Figure 55. Global Antihistamine Drugs: by Route of Administration USD Million (2025-2030)
  • Figure 56. Global Antihistamine Drugs: by Form USD Million (2025-2030)
  • Figure 57. Global Antihistamine Drugs: by Distribution Channel USD Million (2025-2030)
  • Figure 58. South America Antihistamine Drugs Share (%), by Country
  • Figure 59. Asia Pacific Antihistamine Drugs Share (%), by Country
  • Figure 60. Europe Antihistamine Drugs Share (%), by Country
  • Figure 61. MEA Antihistamine Drugs Share (%), by Country
  • Figure 62. North America Antihistamine Drugs Share (%), by Country
  • Figure 63. Global Antihistamine Drugs: by Type K Tons (2025-2030)
  • Figure 64. Global Antihistamine Drugs: by Application K Tons (2025-2030)
  • Figure 65. Global Antihistamine Drugs: by Route of Administration K Tons (2025-2030)
  • Figure 66. Global Antihistamine Drugs: by Form K Tons (2025-2030)
  • Figure 67. Global Antihistamine Drugs: by Distribution Channel K Tons (2025-2030)
  • Figure 68. South America Antihistamine Drugs Share (%), by Country
  • Figure 69. Asia Pacific Antihistamine Drugs Share (%), by Country
  • Figure 70. Europe Antihistamine Drugs Share (%), by Country
  • Figure 71. MEA Antihistamine Drugs Share (%), by Country
  • Figure 72. North America Antihistamine Drugs Share (%), by Country
  • Figure 73. Global Antihistamine Drugs: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Johnson & Johnson Consumer Inc. (United States)
  • Sanofi (France)
  • Bayer AG (Germany)
  • Pfizer (United States)
  • CVS pharmacy (United States)
  • Merck & Co., Inc. (United States)
  • Prestige Brands Holdings, Inc. (United States)
  • Novartis (Switzerland)
  • Teva Pharmaceutical (Israel)
  • Boehringer Ingelheim (Germany)
  • AstraZeneca (United Kingdom)
  • Mylan (United States)
Additional players considered in the study are as follows:
Select User Access Type

Key Highlights of Report


Jul 2024 210 Pages 75 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antihistamine Drugs Market Quantitative research analysis
Global Antihistamine Drugs Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Antihistamine Drugs Market are by type [Sedating [Brompheniramine, Chlorpheniramine, Diphenhydramine, Doxylamine, Carbinoxamine, and Others] and Non-Sedating Antihistamines [Azelastine, Cetirizine, Fexofenadine, Loratadine, Loratadine Odt, and Others]], by end use application [Allergy, Urticaria, Dermatitis, Conjunctivitis and Others].
The Antihistamine Drugs Market is gaining popularity and expected to see strong valuation by 2030.
  • Growing Prevalence of Skin Allergies
  • Rising Geriatric Population

Know More About Global Antihistamine Drugs Market Report?

Have a Query? Click Here

Other Related Reports

Dermatophytosis Drugs Comprehensive Study by Application (Superficial Antifungal Infections, Systemic Antifungal Infections), Route of Administration (Oral, Topical, Parenteral), Form (Powder, Ointme...
$ 3350
Pharmaceutical and Medicinal Herbal Extracts Comprehensive Study by Type (Capsule, Tablet, Powder, Others), Application (Treatment, Massage, Medicines), End-Use (Traditional Chinese Medicine, Western...
$ 3350
Clopidogrel Bisulfate Comprehensive Study by Application (Heart Attacks, Strokes, Peripheral Arterial Diseases), End-users (Hospitals, Clinics, Others), Distribution Channel (Hospital Pharmacies, Ret...
$ 3350
Gemcitabine Comprehensive Study by Application (Pancreas Cancer, Non-Small Cell Lung Cancer, Bladder Cancer, Soft-Tissue Sarcoma, Metastatic Breast Cancer, Ovarian Cancer), Distribution Channel (Hosp...
$ 3450
Antiplatelet Drugs Comprehensive Study by Application (Myocardial Infraction, Percutaneous Coronary Interventions, Angioplasty, Arterial Thrombosis, Dental surgeries, Others), Drug Type (Aspirin, Clo...
$ 3650
Lufenuron Comprehensive Study by Application (Fungal Infections, Ringworm, Agricultural Pesticide, Others), End (Dog, Cat, Other) Players and Region - Global Market Outlook to 2030
$ 3500